Brevan Howard Capital Management LP Arvinas, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 19,249 shares of ARVN stock, worth $172,086. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,249
Previous 12,645
52.23%
Holding current value
$172,086
Previous $311,000
18.65%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
70.8MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$63.1 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$60.1 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$56 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$36.7 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$29.8 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $476M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...